Value is a concept that concerns all healthcare stakeholders.
Regeneron's Eylea won its fourth indication; Sun Pharma wants to revive trust in its products; confidentiality agreements keep Amgen from telling patients their cancer risk
Panelists at a healthcare innovation conference said clinical research and local physician practices need to do more for women's health.
Direct-to-patient approaches can positively impact real world and late phase research programs to increase engagement, retention and data collection.
The drugmaker inks deal with Novo Nordisk to access its biologic discovery research platform.
Keytruda trial stopped due to positive results; new bill proposes continuing FDA rare pediatric voucher program; AstraZeneca signs five-year research pact with Harvard Stem Cell Institute
Delivering smarter dynamic communications rather than static timed communications based on self-reported data can help connect patients to information and support that drive brand loyalty and program success.
An Alliance for Safe Biologic Medicines survey shows what doctors mean by biosimilar transparency.
Angelina Jolie Pitt discloses she had her fallopian tubes and ovaries removed; the FDA's Zyprexa investigation was inconclusive; Takeda and ImmunoGen sign a $20-million deal
Nielsen data shows pharma spent $4.5 billion on DTC ads last year.
Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.
- US pharma market value projected to be $550 billion in five years
- Biosimilar uptake will require companies to tell a trustworthy backstory
- Lawmakers propose allowing pharma companies to share some off-label information
- Apple's ResearchKit: Five Guidelines for Pharma
- Everyday Health buys rare-disease agency Cambridge BioMarketing
- Five things for pharma marketers to know: Thursday, March 26
- Rare Diseases: Target Practice
- Physicians call for emphasis on women's health research and care
- Implement a Direct-to-Patient Approach to Increase Patient Engagement and Retention
- Bristol-Myers Squibb licenses autoimmune program from Novo Nordisk